Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 1 - Micro-organisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving micro-organisms or compositions thereof; Processes of preparing or isolating a composition containing a micro-organism; Culture media therefor
Patents for C12N 1 - Micro-organisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving micro-organisms or compositions thereof; Processes of preparing or isolating a composition containing a micro-organism; Culture media therefor (148,866)
05/2005
05/19/2005WO2005045013A2 Recombinant microorganism
05/19/2005WO2005045004A1 Controlling agent and controlling method for diesease damage on brassicaceous plants
05/19/2005WO2005045003A2 Method for the cultivation of microorganisms of the genus thraustochytriales by using an optimized low salt medium
05/19/2005WO2005045002A2 Nitrite-oxidizing bacteria and methods of using and detecting the same
05/19/2005WO2005044989A2 Polynucleotides and polypeptides of anaplasma phagocytophilum and methods of using the same
05/19/2005WO2005044975A2 Genes encoding carotenoid compounds
05/19/2005WO2005044973A2 NOVEL ACETOACETYL-CoA REDUCTASE AND PROCESS FOR PRODUCING OPTICALLY ACTIVE ALCOHOL
05/19/2005WO2005044844A2 Protozoan strains of reduced virulence and use thereof
05/19/2005WO2005026330B1 Matrix derived from whole organ
05/19/2005WO2004094615A3 Prokaryotic collagen-like proteins and uses thereof
05/19/2005WO2004064776A3 Methods of preparation of live attenuated bacterial vaccines by alteration of dna adenine methylase (dam) activity in those bacteria
05/19/2005WO2004024749A3 Thermostable reverse transcriptases and uses thereof
05/19/2005WO2004016726A3 Methods and compositions for extending the life span and increasing the stress resistance of cells and organisms
05/19/2005WO2004015125A9 Process for preparing peptides with anti-hypertensive properties
05/19/2005WO2004009031A3 Lactobacillus strains and uses therefor
05/19/2005WO2003057713A3 Proteases producing an altered immunogenic response and methods of making and using the same
05/19/2005WO2003029419A3 Three dimensional structure of crystalline grp94 binding domain, and its methods of use
05/19/2005WO2003014703A3 Nucleic acids, polypeptides, single nucleotide polymorphisms and methods of use thereof
05/19/2005US20050108781 Expression vector comprising nucleotide sequences coding heterologous polypeptides for use as gene transfer and expression tool; bioreactors
05/19/2005US20050107961 Apparatus for managing gene expression data
05/19/2005US20050107597 Nucleotide sequences coding microorganismal secondary response gene (SPA-1) for as tool in diagnosis, prevention and treatment of pseudomonal infection
05/19/2005US20050107592 Lipid binding protein 1
05/19/2005US20050107589 Membrane fusion protein for use as toole in the treatment and prevention of inflammatory bowel and autoimmune diseases
05/19/2005US20050107301 administering to a mammal an effective amount of an anti-thrombin protein from the salivary glands of the species, low toxicity, little or no antigenicity, short clearance time from circulation
05/19/2005US20050107293 Protein modification and maintenance polypeptides (PMOD) for use as diagnostic and therapeutic tools in treatment of prevention of gastrointestinal, cardiovascular, autoimmune/inflammatory, cell proliferative, developmental, epithelial, neurological, and reproductive disorders
05/19/2005US20050106734 Fungal micro-organism having an increased ability to carry out biotechnological process(es)
05/19/2005US20050106733 Double-stranded cyclic dna capable of proliferating as a bacterial e coli chromosome
05/19/2005US20050106723 Using matrix immobilized intergrin receptors as adhesion tools in isolation and enrichment of keratinocyte progenitor cells; treating skin disorders
05/19/2005US20050106705 Yeast cultures propagated using alternating electric fields for use in regulation of triglycerides and cholesterol levels in blood
05/19/2005US20050106704 Yeast cultures propagated using alternating electric fields for use in treatment of autoimmune diseases
05/19/2005US20050106702 Surfactant biocatalyst for remediation of recalcitrant organics and heavy metals
05/19/2005US20050106695 Cell-permeable peptide inhibitors of the jnk signal transduction pathway
05/19/2005US20050106693 Metabolically engineered bacterial strains having enhanced 2-keto-D-gluconate accumulation
05/19/2005US20050106688 Using escherichia comprising enhanced concentrations of guanosine-3'-diphosphate-5'-diphosphate as bioreactor for propagation of glutamic acid
05/19/2005US20050106687 Using transgenic gramnegative bacteria as bioreactor for fermentation of threonine for use in medicine, cosmetics and animal feeds
05/19/2005US20050106682 Cytokine receptor protein for use in identifying modulators which prevent hepatitis viral replication and infection; viricides
05/19/2005US20050106680 Interferon-like protein Zcyto21
05/19/2005US20050106679 Leptin proteins
05/19/2005US20050106677 Useful as a candidate for a vaccine against ticks, particularly Ornithodoros moubata
05/19/2005US20050106676 Novel proteins having hemolytic activity and genes encoding the protein
05/19/2005US20050106675 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
05/19/2005US20050106674 Ephrin receptor binding protein for use as tool in treatment and prevention of cell proliferative and nervous system disorders
05/19/2005US20050106670 Isolated human G-protein coupled receptors that are members of the aminergic subfamily, nucleic acid molecules encoding human GPCR proteins, and uses thereof
05/19/2005US20050106668 Proteases from gram-positive organisms
05/19/2005US20050106662 Novel food grade lantibiotic from streptococcus macedonicus and uses thereof
05/19/2005US20050106661 Fluorescent protein
05/19/2005US20050106659 Membrane protein for use as tool in detection of modulators for diagnosis, prevention and treatment of neurological and/or psychiatric diseases
05/19/2005US20050106647 Antibodies with increased affinities for anthrax antigens
05/19/2005US20050106636 Method and kit for detecting membrane protein-protein interactions
05/19/2005US20050106628 MEGSIN protein
05/19/2005US20050106614 Reagents and methods useful for detecting diseases of the prostate
05/19/2005US20050106611 Lipoprotein associated phospholipase A2, inhibitors thereof and use of the same in diagnosis and therapy
05/19/2005US20050106604 Using two-phase isolation to separate and recover biopolymers in solution. electrophoretic separation
05/19/2005US20050106601 Transgenic mouse whose somatic and germ cells express an Fkhsf transgene and mutants; immunomodulators
05/19/2005US20050106599 Nucleotide sequences coding secretfed protein for use as tools in generating antibodies for use in forensics, gene therapeutics and diagnostics and chromosome mapping
05/19/2005US20050106595 Expressed sequence tags and encoded human proteins
05/19/2005US20050106581 Phosphodiesterase polypeptides for use in identifying modulators for prevention and treatment of inflammatory disease
05/19/2005US20050106567 Nucleotide sequences coding tau protein for use as diagnostic tool in detection of alzheimer's and neurodegenerative disorders
05/19/2005US20050106558 Generating viral expression vector comprising parvoviral structural genes for use as gene transfer and expression tool; treatment and prevention of infections, cell proliferative and autoimmune disorders
05/19/2005US20050106553 Rendering material suitable for storage via spraying into hot gas stream an aqueous mixture and carrier, drying mixture to particles , separating partiles from gas stream; storage of materials by incorporating them into water-soluble or water-swellable substance
05/19/2005US20050106176 Vector reproduction using Dna polymerase; linking to chromosome; encoded as foreign gene; genetic engineering
05/19/2005US20050106175 Genetic engineering; gene mutant ; reduced virulence of rodent bone marrow macrophages
05/19/2005US20050106174 Methods and compositions for treating hepatitis b
05/19/2005US20050106173 Methods and compositions for treating male sexual dysfunction
05/19/2005US20050106172 Using yeast cells; culturing in presence of alternating current
05/19/2005US20050106171 Using yest cells cultured in alternating currrent
05/19/2005US20050106170 Methods and compositions for treating vascular dementia
05/19/2005US20050106169 Methods and compositions for treating renal failure
05/19/2005US20050106168 with yeast cells cultured in the presence of an alternating electric field with a specific frequency and field strength to lower urinary protein and increase serum protein; dietary supplement or medication
05/19/2005US20050106167 Methods and compositions for treating gastroparesis
05/19/2005US20050106166 Administering yeast cells; reducing concentration of collagen in liver; controlling concentration of globulins; culture in alternating electric field
05/19/2005US20050106154 GASP1: a follistatin domain containing protein
05/19/2005US20050106145 Anti-human tenascin monoclonal antibody
05/19/2005US20050106143 Collapsin response mediator protein; measurement of gene expression
05/19/2005US20050106140 Antagonistic anti-hfas ligand human antibodies and fragments thereof
05/19/2005US20050106133 Containing lactobacillus; storage stability
05/19/2005US20050106132 Using polyoxyethylene glycol monooleate; storage stability
05/19/2005US20050106099 Fusion proteins
05/19/2005CA2546083A1 Novel brevibacillus choshinensis and method for producing protein using the microorganism as host
05/19/2005CA2545416A1 Process for cultivating microorganisms of the genus thraustochytriales
05/19/2005CA2545410A1 Method for the cultivation of microorganisms of the genus thraustochytriales by using an optimized low salt medium
05/19/2005CA2544821A1 Simian orl1 gene and method of assessing compound
05/19/2005CA2544214A1 Hla-dr-binding antigen peptide derived from wt1
05/19/2005CA2544207A1 Microorganisms producing dipeptides and process for producing dipeptides using the microorganisms
05/19/2005CA2543866A1 Protozoan strains of reduced virulence and use thereof
05/19/2005CA2528574A1 Genes encoding carotenoid compounds
05/18/2005EP1531178A1 Process for preparing and further processing of yeast biomass
05/18/2005EP1530642A2 Use of lactobacillus to produce exopolysaccharides in food and pharmaceutical compositions
05/18/2005EP1530634A2 Modified shine-dalgarno sequences and methods of use thereof
05/18/2005EP1530632A2 Growth factor which acts through erb b-4 rtk
05/18/2005EP1530631A2 Multiply-substituted protease variants
05/18/2005EP1530630A2 Novel lipases and uses thereof
05/18/2005EP1530627A2 System for controlling insects
05/18/2005EP1530586A2 Isolated human secreted proteins, nucleic acid molecules encoding human secreted proteins, and uses thereof
05/18/2005EP1276891B1 A method for enhancing levels of polyunsaturated fatty acids in thraustochytrids
05/18/2005EP1246908B1 Cod uracil-dna glycosylase, gene coding therefore, recombinant dna containing said gene or operative parts thereof, a method for preparing said protein and the use of said protein or said operative parts thereof in monitoring or controlling pcr
05/18/2005EP1212442B1 Enhanced plant cell transformation by addition of host genes involved in t-dna integration
05/18/2005EP1161530B1 Protein for blocking platelet adhesion
05/18/2005EP1145011B1 Compositions and methods for the diagnosis and treatment of tumor
05/18/2005EP0970187B1 Pituitary differentiation factor and methods of use thereof
1 ... 768 769 770 771 772 773 774 775 776 777 778 779 780 781 782 783 784 785 786 787 788 ... 1489